Which research results from the American Society for Radiation Oncology’s 2019 annual meeting are the most interesting or clinically relevant? The staff of Cleveland Clinic Cancer Center’s Department of Radiation Oncology picks their Top 10.
Active surveillance is a viable choice for African-American prostate cancer patients with low- or intermediate-risk disease, enabling long treatment-free periods and reasonable post-treatment outcomes, new Cleveland Clinic research shows.
Cleveland Clinic urologists are playing leading roles in the development of next-generation prostate cancer biomarkers. One new test under investigation, prostate specific antigen/solvent interaction analysis (PSA/SIA), shows promise in improving the diagnostic accuracy of screening and early detection strategies by differentiating PSA structural changes induced by cancer from those of benign glands.